Culturing kidney organoids under fluid flow causes endogenous endothelial...
Culturing kidney organoids under fluid flow causes endogenous endothelial progenitors to create more mature vascular networks which pervade the whole organoid and interact with epithelial compartments.
Source: Wyss Institute at Harvard University

Miniature kidney organoids come of age

Method for growing kidney organoids under flow enhances their vascularization and maturation, increasing their potential for drug testing and regenerative medicine.

In recent years, researchers have created mini-organs known as organoids in the culture dish that contain many of the cell types and complex microarchitectures found in human organs, such as the kidney, liver, intestine, and even the brain. However, most organoids grown in vitro lack the vasculature required to provide oxygen and nutrients, remove metabolic waste, and facilitate communication between different cell types that drives their maturation into truly functional tissue building blocks.

For kidney organoids, this shortcoming prevents researchers from emulating key kidney functions in vitro, including blood filtration, reabsorption, and urine production. Creating robustly vascularized kidney organoids could enable better modeling of kidney diseases, enhance renal drug toxicity testing and, ultimately, lead to new building blocks for renal replacement therapies.

Now, a research team at the Wyss Institute for Biologically Inspired Engineering, the Harvard Paulson School of Engineering and Applied Sciences (SEAS), Brigham and Women’s Hospital, and the Harvard Stem Cell Institute led by Jennifer Lewis and Ryuji Morizane has developed a powerful new approach as part of the Institute’s new 3D Organ Engineering Initiative. By exposing stem cell-derived organoids to fluidic shear stress, they were able to significantly expand organoid-derived vascular networks, and improve the maturation of kidney compartments in comparison to previous static culture methods.

In 2015, Ryuji Morizane and Joseph Bonventre developed a method that enabled them to derive 3D kidney organoids from human pluripotent stem cells. “While our organoids and those generated in other laboratories contained large numbers of well-organized nephrons and primitive blood vessels, they still lacked pervasive vascular compartments with perfusable lumens,” said co-corresponding author Morizane, M.D., Ph.D., Assistant Professor at Brigham and Women’s Hospital and Harvard Medical School (HMS).

More recently, researchers around the world have matured kidney organoids by implanting them into animals where they can connect to the host’s vasculature in vivo. “For the first time, our study demonstrates that by exposing growing organoids to fluid flow, a mechanical cue known to play an important role for tissue development in the body, we can greatly enhance their vascularization and maturation in vitro,” said Morizane.

Photo
A developing glomerulus in a kidney organoid cultured under flow showing invasion by a single capillary, which is an important step in nephron development.
Source: Wyss Institute at Harvard University

To accomplish this feat, the team used expertise from the Lewis lab that has pioneered strategies to create vascularized human tissues, including 3D kidney-on-chip models, using 3D bioprinting that can be perfused and sustained for long durations. Based on these findings, they hypothesized that fluid flow could also promote the formation of blood vessels from precursor endothelial cells found in growing kidney organoids.

“We determined the right combination of underlying extracellular matrix, media additives, and fluidic shear stress under which human stem-cell derived organoids would flourish when grown in our 3D-printed millifluidic chips,” said Kimberly Homan, Ph.D., who with Navin Gupta, M.D., is a first author on the study. Gupta added that “the vascular networks form close to the epithelial structures that build the glomerular and tubular compartments, and in turn promote epithelial maturation. This integrated process works really like a two-way street.” Homan is a Research Associate in Lewis’ group at the Wyss Institute and SEAS, and Gupta is a Clinical Research Fellow working on Morizane’s team at the Brigham.

The vessels growing on the 3D-printed chips form an interconnected network with open lumens, which can be perfused with fluids as confirmed by directly imaging fluorescent beads moving freely through them. “We were excited to see that these vascularized glomerular and tubular structures develop through some of the same stages that nephrons experience during normal kidney development in vivo,” said Homan.

“This important advance opens up new avenues for accurately testing drug toxicity in vitro in differentiated nephron compartments and modeling kidney diseases, like polycystic kidney disease, that affect specific structures and cell types using patient-derived stem cells as the starting point,” said co-corresponding author Lewis, Sc.D., who is a Core Faculty member of the Wyss Institute and co-leader of its 3D Organ Engineering Initiative. “Our method may pave the way to also vascularize other types of organoids, such as the liver organoids.” Lewis is also the Hansjörg Wyss Professor of Biologically Inspired Engineering at SEAS.

“This study is a great example of the importance of mechanobiology and the potential power of the Wyss Institute’s 3D Organ Engineering Initiative. It provides an important cornerstone for many efforts that aim to create functional human tissues de novo for research, pharmaceutical and tissue regenerative applications,” said Wyss Institute Founding Director Donald Ingber, M.D., Ph.D.

Subscribe to our newsletter

Related articles

Oxygen-releasing bioink for bioprinting

Oxygen-releasing bioink for bioprinting

Researchers have developed an oxygen-releasing bioink that may be useful in 3D printing bioengineered cell constructs.

Sugar: Sweet way to 3D print blood vessels

Sugar: Sweet way to 3D print blood vessels

Scientists have developed a way of using laser-sintering of powdered sugars to produce highly detailed structures that mimick the body’s intricate, branching blood vessels in lab-grown tissues.

Researchers successfully bioprint healthy new tissue

Researchers successfully bioprint healthy new tissue

New muscle has successfully been created in mice using a minimally invasive technique dubbed ‘intravital 3D bioprinting’.

Transparent human organs allow 3D maps at the cellular level

Transparent human organs allow 3D maps at the cellular level

For the first time, researchers managed to make intact human organs transparent. Using microscopic imaging they could revealed underlying complex structures of the see-through organs at the cellular level.

One step closer to bioprinting the human heart

One step closer to bioprinting the human heart

Researchers have developed a technique to 3D bioprint collagen, allowing them to fabricate fully functional components of the human heart.

3D printing of biological tissue

3D printing of biological tissue

Scientists hope we will soon be using 3D-printed biologically functional tissue to replace irreparably damaged tissue in the body.

Research programme to bioprint ear and noses launched

Research programme to bioprint ear and noses launched

The Scar Free Foundation has launched a research programme that aims to revolutionise surgeons’ ability to reconstruct nose and ear cartilage in patients affected by facial difference.

Bioprinter speeds up drug development

Bioprinter speeds up drug development

A 3D printer that rapidly produces large batches of custom biological tissues could help make drug development faster and less costly.

Bioprinting mini pancreas to fight against diabetes

Bioprinting mini pancreas to fight against diabetes

EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds.

Popular articles

Subscribe to Newsletter